Filing Details
- Accession Number:
- 0000950170-24-101059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-27 16:49:19
- Reporting Period:
- 2024-08-23
- Accepted Time:
- 2024-08-27 16:49:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1861560 | Nuvalent Inc. | NUVL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2029477 | E. Henry Pelish | C/O Nuvalent, Inc. One Broadway, 14Th Floor Cambridge MA 02142 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2024-08-23 | 10,500 | $85.08 | 66,095 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2023.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.30, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
